KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 66 filers reported holding KURA ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $63,000 | -95.9% | 2,218 | -94.6% | 0.00% | -100.0% |
| Q4 2020 | $1,536,000 | +15.9% | 41,188 | -3.2% | 0.00% | 0.0% |
| Q3 2020 | $1,325,000 | +105.1% | 42,534 | +17.8% | 0.00% | 0.0% |
| Q2 2020 | $646,000 | +864.2% | 36,118 | +646.5% | 0.00% | – |
| Q4 2019 | $67,000 | +45.7% | 4,838 | +60.7% | 0.00% | – |
| Q3 2019 | $46,000 | -6.1% | 3,010 | +22.1% | 0.00% | – |
| Q2 2019 | $49,000 | – | 2,465 | +82066.7% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 3 | -99.2% | 0.00% | – |
| Q4 2018 | $6,000 | +100.0% | 400 | +105.1% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 195 | +10.8% | 0.00% | – |
| Q2 2018 | $3,000 | -97.9% | 176 | -97.7% | 0.00% | – |
| Q1 2018 | $144,000 | -4.0% | 7,636 | -22.4% | 0.00% | – |
| Q4 2017 | $150,000 | -97.5% | 9,834 | -97.6% | 0.00% | -100.0% |
| Q3 2017 | $6,018,000 | – | 402,434 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |